Curriculum Vitae: Gordon R. Ray, M.D.
Education
M.D., University of Miami School of Medicine, Miami, FL 1963-67
B.S. (Biochemistry), Adelphi University, Garden City, NY 1959-63 Current Positions
Chairman, Department of Radiation Oncology 1986-present
Palo Alto Medical Foundation ph# (650) 853-2954
300 Homer Avenue fax# (650) 853-6064
Palo Alto, CA 94301
Clinical Professor, Division of Radiation Therapy 1988-present Post-Doctoral Training and Experience
Stanford University Medical Center, Stanford, CA
Chairman, Membership and Audit Committee 1982-88
Northern California Oncology Group
Chairman, Radiation Quality Control Committee 1978-88
Northern California Oncology Group
Associate Director, Division of Radiation Oncology 1975-85
Palo Alto Medical Foundation, Palo Alto, CA
Clinical Associate Professor, Division of Radiation Therapy 1974-88
Stanford University Medical Center, Stanford, CA
Assistant Professor, Department of Radiology 1972-74
Stanford University Medical Center, Stanford, CA
Board Eligible 1972
Instructor, Department of Radiology, Division of Radiation Therapy 1971-72
Stanford University Medical Center, Stanford, CA
Post-doctoral Fellow, Department of Radiology 1968-71
Stanford University School of Medicine, Stanford, CA
Internship: USC Medical Center 1967-68 Honors
B.S. Magna Cum Laude
Chairman and President, Adelphi Judicial Board and Senior Men's Honorary Membership
Executive Board, American Cancer Society 1988-89
American Society for Clinical Oncology 1983
American Society of Therapeutic Radiologists 1981
Northern California Radiological Society 1978
Chairman, Professional Education Committee, American Cancer Society 1976-77
Professional Education Committee, American Cancer Society 1975-76
Military Service
Lt. Commander, Head, Department of Radiation Therapy 1972-75 Licensure
U.S. Naval Hospital, Oak Knoll, CA
California
New Mexico Hospital Privileges
Stanford University Hospital
Kaiser Santa Clara Publications
1. Ray GR , Adelson J, Hayhurst E, Marzoni A, Gregg D, Bronk M, McClenathan J, Bitar N, Macio I. Ductal carcinoma in situ of the breast: results of treatment by conservative surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 1994 Jan 1; 28(1):105-111
2. Bagshaw MA, Cox RS, Ray GR . Status of radiation treatment of prostate cancer at Stanford University. NCI Monogr 1988; 7:47-60
3. Bagshaw MA, Cox RS, Ray GR . Selecting initial therapy for prostate cancer. Radiation therapy perspective. Cancer 1987 Aug 1;60(3 Suppl):521-525
4. Bagshaw MA, Ray GR , Cox RS. Long term results in radiotherapy of prostatic cancer. Prog Clin Biol Res 1987;243B:107-120
5. Bagshaw MA, Ray GR , Cox RS. Radiotherapy of prostatic carcinoma: long- or short-term efficacy (Stanford University experience). Urology 1985 Feb;25(2 Suppl):17-23
6. Ray GR , Bagshaw MA, Freiha F. External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy. J Urol 1984 Nov;132(5):926-930
7. Ray GR , Fish VJ, Marmor JB, Rogoway W, Kushlan P, Arnold C, Lee RH, Marzoni F. Impact of adjuvant chemotherapy on cosmesis and complications in Stages I and II carcinoma of the breast treated by biopsy and radiation therapy. Int J Radiat Oncol Biol Phys 1984 Jun;10(6):837-841
8. Levine JF, Coleman CN, Cox RS, Ray GR , Rogoway WM, Martinez A, Stockdale FE. The effect of postoperative and primary radiation therapy on delivered dose of adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy in breast cancer. Cancer 1984 Jan 15;53(2):237-241
9. Ray GR , Fish VJ. Biopsy and definitive radiation therapy in Stages I and II adenocarcinoma of the female breast: analysis of cosmesis and the role of the electron beam supplementation. Int J Radiat Oncol Biol Phys 1983 Jun;9(6):813-818
10. Ray GR , Fish VJ, Lee RH, Marzoni FA, Trollope ML, Hews M, Gribble M. Biopsy and definitive radiation therapy in Stages I and II carcinoma of the female breast. Int J Radiat Oncol Biol Phys 1983 Jan;9(1):23-28
11. MacDonald EA, Meurk ML, Ray G , Phillips TL, Carter SK. Radiotherapy in cooperative clinical trials: Northern California Oncology Group (NCOG) method. Int J Radiat Oncol Biol Phys 1980 Sep;6(9):1207-1213
12. Spellman MC, Castellino RA, Ray GR , Pistenma DA, Bagshaw MA. An evaluation of lymphography in localized carcinoma of the prostate. Radiology 1977 Dec;125(3):637-644
13. Ray GR . Adenocarcinoma of the prostate: the need for standardized, controlled, prospective trials and less empiricism. Int J Radiat Oncol Biol Phys 1977 Sep;2(9-10):1041-1044
14. Bagshaw MA, Pistenma DA, Ray GR , Freiha FS, Kempson RL. Evaluation of extended-field radiotherapy for prostatic neoplasm: 1976 progress report. Cancer Treat Rep 1977 Mar;61(2):297-306
15. Ray GR , Pistenma DA, Castellino RA, Kempson RL, Meares E, Bagshaw MA. Operative staging of apparently localized adenocarcinoma of the prostate: results in fifty unselected patients. I. Experimental design and preliminary results. Cancer 1976 Jul;38(1):73-83
16. Pistenma DA, Ray GR , Bagshaw MA. The role of megavoltage radiation therapy in the treatment of prostatic carcinoma. Semin Oncol 1976 Jun;3(2):115-122
17. Horn NL, Ray GR , Kriss JP. Gallium-67 citrate scanning in Hodgkin's disease and non-Hodgkin's lymphoma. Cancer 1976 Jan;37(1):250-257
18. Goffinet DR, Schneider MJ, Glatstein EJ, Ludwig H, Ray GR , Dunnick NR, Bagshaw MA. Bladder cancer: results of radiation therapy in 384 patients. Radiology 1975 Oct;117(1):149-153
19. Bagshaw MA, Ray GR , Pistenma DA, Castellino RA, Meares EM. External beam radiation therapy of primary carcinoma of the prostate. Cancer 1975 Aug;36(2):723-728
20. Ray GR , Cassady JR, Bagshaw MA. External-beam megavoltage radiation therapy in the treatment of post-radical prostatectomy residual or recurrent tumor preliminary results. J Urol 1975 Jul;114(1):98-101
21. Ray GR , Bagshaw MA. The role of radiation therapy in the definitive treatment of adenocarcinoma of the prostate. Annu Rev Med 1975;26:567-588
22. Bagshaw MA, Ray GR , Salzman JR, Meares, EM Jr: Extended-field radiation therapy for carcinoma of the prostate: a progress report. Cancer Chemother Rep 1975 Jan;59(1):165-173
23. Bagshaw MA, Ray GR . Modern radiation therapy of carcinoma of the prostate. J Radiol Electrol Med Nucl 1974 Nov;55(11):798-802
24. Ray GR , Hahn GM, Bagshaw MA, Kurkjian S. Cell survival and repair of plateau-phase cultures after chemotherapy--relevance to tumor therapy and to the in vitro screening of new agents. Cancer Chemother Rep 1973 Nov;57(4):473-475
25. Ray GR , Wolf PH, Kaplan HS. Value of laboratory indicators in Hodgkin's disease: preliminary results. Natl Cancer Inst Monogr 1973 May;36:315-323
26. Ray GR , Cassady JR, Bagshaw MA. Definitive radiation therapy of carcinoma of the prostate. A report on 15 years of experience. Radiology 1973 Feb;106(2):407-418
27. Hahn GM, Ray GR , Gordon LF, Kallman RF. Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure. J Natl Cancer Inst 1973 Feb;50(2):529-533
28. Castellino RA, Ray G , Blank N, Govan D, Bagshaw M. Lymphangiography in prostatic carcinoma. Preliminary observations. JAMA 1973 Feb 19;223(8):877-881
29. Bagshaw MA, Ray GR . Proceedings: Prostate carcinoma: external irradiation as definitive treatment. Proc Natl Cancer Conf 1972;7:761-767
30. Ray GR , DeNardo GL, King GH. Localization of strontium 85 in soft tissue infected by Aspergillus niger. Radiology 1971 Oct;101(1):119-123
31. Ray GR , Trueblood HW, Enright LP, Kaplan HS, Nelsen TS. Oophoropexy: a means of preserving ovarian function following pelvic megavoltage radiotherapy for Hodgkin's disease. Radiology 1970 Jul;96(1):175-180
32. Trueblood HW, Enright LP, Ray GR , Kaplan HS, Nelsen TS. Preservation of ovarian function in pelvic radiation for Hodgkin's disease. Arch Surg 1970 Mar;100(3):236-237
33. Matin P, Ray G , Kriss JP. Combined superior vena cava obstruction and pericardial effusion demonstrated by radioisotopic angiocardiography. J Nucl Med 1970 Feb;11(2):78-80